Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.30 USD
Change Today -0.06 / -2.54%
Volume 9.5K
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

bovie medical corp (BVX) Key Developments

Bovie Medical Corporation Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Bovie Medical Corporation announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported sales of $7,274,000 against $6,945,000 a year ago. Loss from operations was $1,548,000 against $1,746,000 a year ago. Loss before income taxes was $1,497,000 against $332,000 a year ago. Net loss was $1,497,000 or $0.06 per diluted share against net income of $251,000 or $0.07 per diluted share a year ago. Adjusted net loss was $1,587,000 or $0.06 per basic and diluted share against $460,000 or $0.03 per basic and diluted share a year ago. For the six months, the company reported sales of $13,402,000 against $13,427,000 a year ago. Loss from operations was $3,821,000 against $1,687,000 a year ago. Loss before income taxes was $2,367,000 against $9,901,000 a year ago. Net loss was $2,375,000 or $0.41 per diluted share against $9,356,000 or $0.55 per diluted share a year ago. Adjusted net loss was $3,909,000 or $0.18 per basic and diluted share against $536,000 or $0.03 per basic and diluted share a year ago.

Bovie Medical Corporation to Report Q2, 2015 Results on Aug 06, 2015

Bovie Medical Corporation announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Aug 06, 2015

Bovie Medical Corporation, Q2 2015 Earnings Call, Aug 06, 2015

Bovie Medical Corporation, Q2 2015 Earnings Call, Aug 06, 2015

Bovie Medical Corporation Announces Executive Changes

Bovie Medical Corporation announced that Peter L. Donato, Chief Financial Officer and Secretary of Bovie Medical Corporation, intends to resign from his service as Chief Financial Officer, Executive Vice President, Treasurer and Secretary of the Company on or about June 25, 2015. On June 15, 2015, the Board of Directors of the Company appointed Jay Ewers, currently the Controller of the Company, as the Interim Chief Financial Officer, Treasurer and Secretary of the Company effective upon Mr. Donato’s resignation. Mr. Ewers has more than 30 years of senior experience and has held financial executive positions in corporations ranging from early stage to high profile public companies with global operations in the medical equipment, manufacturing and semiconductor industries. He has extensive experience with Sarbanes Oxley, inventory management, Oracle modules and financial planning & analysis. Bovie Medical will engage an executive search firm to conduct a search for a permanent CFO.

Bovie Medical Corporation, Annual General Meeting, Jul 16, 2015

Bovie Medical Corporation, Annual General Meeting, Jul 16, 2015., at 14:00 US Eastern Standard Time. Location: offices of Ruskin Moscou Faltischek, P.C.. Agenda: To elect seven directors to the board of directors of the company to serve until the 2016 annual meeting of stockholders; to approve the 2015 Share Incentive Plan; to ratify Frazier & Deeter, LLC as independent registered public accounting firm for the company for the fiscal year ending December 31, 2015; to approve a non-binding advisory resolution supporting the compensation of its named executive officers; and to transact such other business that may properly come before the meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BVX:US $2.30 USD -0.06

BVX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IRIDEX Corp $6.89 USD +0.17
MGC Diagnostics Corp $5.25 USD +0.22
Misonix Inc $11.37 USD +0.39
Stereotaxis Inc $1.80 USD +0.229
Synergetics USA Inc $4.35 USD -0.04
View Industry Companies
 

Industry Analysis

BVX

Industry Average

Valuation BVX Industry Range
Price/Earnings 16.5x
Price/Sales 2.0x
Price/Book 2.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BOVIE MEDICAL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.